BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28545270)

  • 21. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
    Sun Y; Si L
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb; 24(1):29-32. PubMed ID: 7781112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional variant of the P2X7 receptor gene is associated with human papillomavirus-16 positive cervical squamous cell carcinoma.
    Yang YC; Chang TY; Chen TC; Lin WS; Chang SC; Lee YJ
    Oncotarget; 2016 Dec; 7(50):82798-82803. PubMed ID: 27779103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53, MDM2, NQO1, and susceptibility to cervical cancer.
    Hu X; Zhang Z; Ma D; Huettner PC; Massad LS; Nguyen L; Borecki I; Rader JS
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):755-61. PubMed ID: 20200430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H
    Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.
    Lai ZZ; Ni-Zhang ; Pan XL; Song L
    J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
    Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
    Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
    Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
    Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus Type 16
    Yao Y; Yan Z; Dai S; Li C; Yang L; Liu S; Zhang X; Shi L; Yao Y
    Int J Med Sci; 2019; 16(7):1042-1049. PubMed ID: 31341418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.
    Chansaenroj J; Theamboonlers A; Junyangdikul P; Swangvaree S; Karalak A; Chinchai T; Poovorawan Y
    Asian Pac J Cancer Prev; 2013; 14(1):341-6. PubMed ID: 23534750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells.
    Oliveira S; Sousa H; Santos AM; Pinto D; Pinto-Correia AL; Fontoura D; Moutinho J; Medeiros R
    J Med Virol; 2008 Mar; 80(3):424-9. PubMed ID: 18205229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
    Zhao W; Si J; Li K
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single nucleotide polymorphisms and haplotypes of carbonic anhydrase 9 can predict invasive squamous cell carcinoma of uterine cervix.
    Shen HP; Hsiao YH; Yang SF; Liu YF; Ko JL; Wang PH
    Int J Med Sci; 2018; 15(6):587-594. PubMed ID: 29725249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR Promoter Methylation, EGFR Mutation, and HPV Infection in Chinese Cervical Squamous Cell Carcinoma.
    Zhang W; Jiang Y; Yu Q; Qiang S; Liang P; Gao Y; Zhao X; Liu W; Zhang J
    Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):661-6. PubMed ID: 25789535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
    Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
    Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
    El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
    Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homozygous arginine at codon 72 of p53 has no prognostic significance in cervical cancer.
    Ngan HY; Liu VW; Liu SS; Cheng DK; Ng TY; Wong LC
    Tumour Biol; 2000; 21(3):135-8. PubMed ID: 10754463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low frequency of p53 mutations in cervical carcinomas among Brazilian women.
    Pinheiro NA; Villa LL
    Braz J Med Biol Res; 2001 Jun; 34(6):727-33. PubMed ID: 11378660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
    Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
    BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
    Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix.
    Giannoudis A; Graham DA; Southern SA; Herrington CS
    Int J Cancer; 1999 Sep; 83(1):66-9. PubMed ID: 10449610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.